Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2005 1
2006 1
2008 2
2009 3
2010 2
2011 2
2012 5
2013 2
2014 2
2015 2
2016 3
2017 1
2018 1
2019 3
2020 5
2021 8
2022 8
2023 7
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Challenges in glioblastoma research: focus on the tumor microenvironment.
Bikfalvi A, da Costa CA, Avril T, Barnier JV, Bauchet L, Brisson L, Cartron PF, Castel H, Chevet E, Chneiweiss H, Clavreul A, Constantin B, Coronas V, Daubon T, Dontenwill M, Ducray F, Enz-Werle N, Figarella-Branger D, Fournier I, Frenel JS, Gabut M, Galli T, Gavard J, Huberfeld G, Hugnot JP, Idbaih A, Junier MP, Mathivet T, Menei P, Meyronet D, Mirjolet C, Morin F, Mosser J, Moyal EC, Rousseau V, Salzet M, Sanson M, Seano G, Tabouret E, Tchoghandjian A, Turchi L, Vallette FM, Vats S, Verreault M, Virolle T. Bikfalvi A, et al. Among authors: dontenwill m. Trends Cancer. 2023 Jan;9(1):9-27. doi: 10.1016/j.trecan.2022.09.005. Epub 2022 Nov 16. Trends Cancer. 2023. PMID: 36400694 Review.
Glioblastoma Metabolism: Insights and Therapeutic Strategies.
Bernhard C, Reita D, Martin S, Entz-Werle N, Dontenwill M. Bernhard C, et al. Among authors: dontenwill m. Int J Mol Sci. 2023 May 23;24(11):9137. doi: 10.3390/ijms24119137. Int J Mol Sci. 2023. PMID: 37298093 Free PMC article. Review.
Challenges in glioblastoma research: focus on the tumor microenvironment: (Trends in Cancer, 9:1 p:9-27, 2023).
Bikfalvi A, da Costa CA, Avril T, Barnier JV, Bauchet L, Brisson L, Cartron PF, Castel H, Chevet E, Chneiweiss H, Clavreul A, Constantin B, Coronas V, Daubon T, Dontenwill M, Ducray F, Entz-Werlé N, Figarella-Branger D, Fournier I, Frenel JS, Gabut M, Galli T, Gavard J, Huberfeld G, Hugnot JP, Idbaih A, Junier MP, Mathivet T, Menei P, Meyronet D, Mirjolet C, Morin F, Mosser J, Moyal EC, Rousseau V, Salzet M, Sanson M, Seano G, Tabouret E, Tchoghandjian A, Turchi L, Vallette FM, Vats S, Verreault M, Virolle T. Bikfalvi A, et al. Among authors: dontenwill m. Trends Cancer. 2023 Aug;9(8):692. doi: 10.1016/j.trecan.2023.02.006. Epub 2023 Mar 28. Trends Cancer. 2023. PMID: 36997420 No abstract available.
Biological Relevance of RGD-Integrin Subtype-Specific Ligands in Cancer.
Sani S, Messe M, Fuchs Q, Pierrevelcin M, Laquerriere P, Entz-Werle N, Reita D, Etienne-Selloum N, Bruban V, Choulier L, Martin S, Dontenwill M. Sani S, et al. Among authors: dontenwill m. Chembiochem. 2021 Apr 6;22(7):1151-1160. doi: 10.1002/cbic.202000626. Epub 2020 Nov 27. Chembiochem. 2021. PMID: 33140906 Review.
β1 Integrins as Therapeutic Targets to Disrupt Hallmarks of Cancer.
Blandin AF, Renner G, Lehmann M, Lelong-Rebel I, Martin S, Dontenwill M. Blandin AF, et al. Among authors: dontenwill m. Front Pharmacol. 2015 Nov 24;6:279. doi: 10.3389/fphar.2015.00279. eCollection 2015. Front Pharmacol. 2015. PMID: 26635609 Free PMC article. Review.
56 results